Flucloxacillin Dosing for Cellulitis in Adults
Recommended Dosage
For uncomplicated cellulitis in otherwise healthy adults, flucloxacillin 500 mg orally four times daily for 5-7 days is the standard recommended dose. 1, 2, 3
Clinical Context and Evidence
Standard Dosing Regimen
- Flucloxacillin 500 mg four times daily is the established dose used in multiple clinical trials for outpatient cellulitis treatment 1, 2, 3
- Treatment duration is typically 5-7 days for uncomplicated cases 2
- This regimen targets β-hemolytic streptococci and methicillin-sensitive Staphylococcus aureus, the primary pathogens in non-purulent cellulitis 4
Monotherapy vs. Combination Therapy
- Flucloxacillin alone is sufficient for most cases of cellulitis 1
- Adding phenoxymethylpenicillin to flucloxacillin provides no additional benefit in clinical trials 1
- Adding clindamycin to flucloxacillin does not improve outcomes but significantly increases diarrhea risk (22% vs 9%) 2
Treatment Setting
- Outpatient oral therapy is appropriate for patients without systemic inflammatory response syndrome (SIRS), altered mental status, or hemodynamic instability 5
- Hospitalization should be considered if there is concern for deeper/necrotizing infection, poor adherence, severe immunocompromise, or outpatient treatment failure 5
Important Caveats
Dosing Adjustments
- No renal adjustment needed for flucloxacillin at standard doses in patients with normal kidney function
- For patients with severe renal impairment, consider alternative agents or dose reduction based on creatinine clearance
Treatment Monitoring
- Clinical improvement should be evident by day 5, with reduction in fever, skin temperature, or affected area circumference 2
- Treatment failure rate is approximately 12-20% with standard oral antibiotics 2, 6
- If no improvement by day 5 or worsening symptoms, reassess for complications or alternative diagnoses 2
Common Pitfalls
- Do not routinely cover for MRSA in non-purulent cellulitis, even with rising community-acquired MRSA rates 4
- Avoid unnecessary combination therapy that increases side effects without improving outcomes 2
- Ensure adequate treatment duration to prevent recurrence; inadequate treatment periods may lead to relapse 5